Healthcare and Pharmaceuticals

Gilead: Cultivating the Pipeline

April 24, 2017 / by Jason Cheung and Dennis Zhan / 0 Comment

In order to restore investor confidence and hedge legacy market downturns, Gilead needs to diversify into other channels of sustainable revenue generation to minimize volatility


0

The Biosimilar Onslaught

January 05, 2016 / by Kevin Shi and Nawid Sayed / 0 Comment

Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.


0

The Aurora Edge

December 19, 2015 / by Dilara Alpi and Michael Lickver / 0 Comment

How the newest player in Canada’s medical marijuana industry can smoke out the competition

Revitalizing Medical Care

April 04, 2012 / by Geoff Calder and Nadeem Nathoo / 0 Comment

The search for ubiquity in a broken system.

The Perfect Remedy

January 04, 2012 / by David Stewart and Sabriya Karim / 0 Comment

Could drug incubation allow Canada to better compete in the global pharmaceutical industry?

A Healthy Getaway

April 04, 2011 / by David Stewart and Sabriya Karim / 0 Comment

Can medical tourism improve healthcare for Canadians?

The Big Pharma Bust

April 03, 2010 / by Juthika Thakur / 0 Comment

The collapse of Western pharmaceutical companies is inevitable